61695-63-4

Basic information

• Product Name: 2,6-dihydroxy-4-pentylbenzoic acid
• CAS NO: 61695-63-4
• Molecular Formula: C₁₂H₁₆O₄
• Molecular Weight: 224.253
• Mol File: 61695-63-4.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 392.6°C at 760 mmHg
• Flash Point: 205.4°C
• Density: 1.237g/cm³
• Vapor Pressure: 7.2E-07mmHg at 25°C
• Refractive Index: 1.581
• CAS DataBase Reference: 2,6-dihydroxy-4-pentylbenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2,6-dihydroxy-4-pentylbenzoic acid(61695-63-4)
• EPA Substance Registry System: 2,6-dihydroxy-4-pentylbenzoic acid(61695-63-4)

Safety Data

• Hazardous Substances Data: 61695-63-4(Hazardous Substances Data)

Upstream product

• 124-38-9 carbon dioxide 
• 500-66-3 Olivetol 
• 298-14-6 potassium hydrogencarbonate 
• 491-47-4 olivetoric acid 

Downstream Products

• 83578-32-9 methyl 2,6-dihydroxy-4-pentylbenzoate 

Relevant articles and documents

Regioselective ortho-carboxylation of phenols catalyzed by benzoic acid decarboxylases: A biocatalytic equivalent to the Kolbe-Schmitt reaction

The enzyme catalyzed carboxylation of electron-rich phenol derivatives employing recombinant benzoic acid decarboxylases at the expense of bicarbonate as CO2 source is reported. In contrast to the classic Kolbe-Schmitt reaction, the biocatalytic equivalent proceeded in a highly regioselective fashion exclusively at the ortho-position of the phenolic directing group in up to 80% conversion. Several enzymes were identified, which displayed a remarkably broad substrate scope encompassing alkyl, alkoxy, halo and amino- functionalities. Based on the crystal structure and molecular docking simulations, a mechanistic proposal for 2,6-dihydroxybenzoic acid decarboxylase is presented.

Biomimetic synthesis of the tetracyclic core of berkelic acid

Acid-catalyzed condensation of 2,6-dihydroxybenzoic acid 3 with ketal aldehyde 14 in methanol at 25 °C, followed by CH2N2 esterification, gave a 4:1:4:1 mixture of diastereomers 15b-18b in 60% yield. Equilibration of this mixture wit

Selective protein tyrosine phosphatatase inhibitors

Compounds of formula (I) or therapeutically acceptable salts thereof, are selective protein tyrosine kinase-B (PTP1B) inhibitors. Preparation of the compounds, compositions containing the compounds, and treatment of disorders using the compounds are disclosed.